Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rockwell Medical (RMTI) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Rockwell Medical (RMTI) over the last 17 years, with Q3 2025 value amounting to $3.3 million.

  • Rockwell Medical's Operating Expenses fell 704.5% to $3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.6 million, marking a year-over-year decrease of 67.9%. This contributed to the annual value of $14.1 million for FY2024, which is 662.69% up from last year.
  • According to the latest figures from Q3 2025, Rockwell Medical's Operating Expenses is $3.3 million, which was down 704.5% from $3.3 million recorded in Q2 2025.
  • Rockwell Medical's Operating Expenses' 5-year high stood at $6.1 million during Q2 2021, with a 5-year trough of $2.9 million in Q4 2023.
  • Moreover, its 5-year median value for Operating Expenses was $3.7 million (2025), whereas its average is $4.1 million.
  • Its Operating Expenses has fluctuated over the past 5 years, first soared by 3579.23% in 2021, then tumbled by 3927.38% in 2023.
  • Over the past 5 years, Rockwell Medical's Operating Expenses (Quarter) stood at $5.3 million in 2021, then fell by 24.74% to $4.0 million in 2022, then decreased by 27.28% to $2.9 million in 2023, then grew by 14.99% to $3.3 million in 2024, then increased by 0.54% to $3.3 million in 2025.
  • Its last three reported values are $3.3 million in Q3 2025, $3.3 million for Q2 2025, and $3.7 million during Q1 2025.